latbrain.com

LATBrain Symposium 2022

October 27th and 28th

INVITATION


For three years, more than ten countries in Latin America and the Caribbean have begun to work on the Latin American Brain Initiative (LATBrain) to strengthen cooperation bridges between the countries of the area and thus be able to detect the main problems related to with the Nervous System, both in health and pathological conditions, to address them jointly.

In 2021 we held a (virtual) Symposium on COVID-19 and the Brain, which was attended by hundreds of attendees.

In this instance, we are inviting the LATBrain Symposium 2022, under the title:

“Current status and challenges of research in neurodegenerative diseases and epilepsy in Latin America,” to be held virtually on October 27th and 28th on the UNAH platform.

Attendance is free, with prior registration.

We invite you to attend and present posters of research carried out or projects in progress on the proposed topics: Alzheimer’s and related Dementias, Parkinson’s, Epilepsy, and Neuromuscular Diseases.

Registration to attend and/or to submit posters

The submission deadline is October 10th.

Hoping to have your assistance and your communications (posters)

We greet you fraternally,

Organizing Committee of the LATBrain Symposium 2022

CoPEs (LATBrain Strategic Planning Committee)

 

PRELIMINARY PROGRAM

Alzheimer's disease
“It has been reported that during the last decade, Latin American countries have reported a high prevalence of dementia, ranging between 6.2 and 12.1%, among people older than 65 years.” (Llibre-Guerra et al., 2020. Alzheimer & Dementia)

Parkinson's disease
“In Latin American countries, a prevalence of Parkinsonism of 8.0% and a prevalence of Parkinson’s Disease of 2.0% have been reported in people over 65 years of age. (Llibre-Guerra et al., 2022. The Lancet)

Neuromuscular diseases
In Latin America, patients with hereditary neuromuscular diseases (MND) often do not have access to specialized medical centers and many of them are not diagnosed.” (Monges et al., 2017. Gene Therapy)

Epilepsy
"More than 50% of people with epilepsy do not receive medical care in Latin America" (ONU)

latbrain2021

Add comment